NIH rewrites the pandemic playbook By HPN Staff Key Points Jay Bhattacharya and Matthew Memoli argue the traditional U.S. pandemic playbook failed, criticizing gain-of-function research, pathogen hunting, and stockpiling sp... Read more Remember the food pyramid? It may be coming back By HPN staff Key Points HHS Secretary Robert F. Kennedy Jr. is signaling a major overhaul of federal dietary guidance, possibly bringing back a simplified visual tool like the food pyramid... Read more Better long-term care for billions less By Stephen Moses Key Points The article argues that Medicaid’s current structure encourages middle-class and affluent individuals to preserve assets for heirs rather than plan responsibly ... Read more Global anti-tobacco summit calls for vape flavor bans By HPN Staff Key Points Although the United States has not ratified the WHO Framework Convention on Tobacco Control, its policies exert significant indirect influence on U.S. state and loc... Read more The future of small businesses depends on affordable healthcare By Marcie Strouse Key Points Small businesses face a severe affordability crisis in providing employer-sponsored health insurance, with premiums rising more than 120 percent since 2000 an... Read more FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7 MOST VIEWED 1 GAO says ACA fraud is rampant 2 States to receive an average of $200M for rural healthcare 3 U.S. nutrition guidelines shift back toward a pyramid — but with a twist 4 Advocates in Massachusetts look to reverse recreational marijuana legalization DONATE
Remember the food pyramid? It may be coming back By HPN staff Key Points HHS Secretary Robert F. Kennedy Jr. is signaling a major overhaul of federal dietary guidance, possibly bringing back a simplified visual tool like the food pyramid... Read more Better long-term care for billions less By Stephen Moses Key Points The article argues that Medicaid’s current structure encourages middle-class and affluent individuals to preserve assets for heirs rather than plan responsibly ... Read more Global anti-tobacco summit calls for vape flavor bans By HPN Staff Key Points Although the United States has not ratified the WHO Framework Convention on Tobacco Control, its policies exert significant indirect influence on U.S. state and loc... Read more The future of small businesses depends on affordable healthcare By Marcie Strouse Key Points Small businesses face a severe affordability crisis in providing employer-sponsored health insurance, with premiums rising more than 120 percent since 2000 an... Read more FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
Better long-term care for billions less By Stephen Moses Key Points The article argues that Medicaid’s current structure encourages middle-class and affluent individuals to preserve assets for heirs rather than plan responsibly ... Read more Global anti-tobacco summit calls for vape flavor bans By HPN Staff Key Points Although the United States has not ratified the WHO Framework Convention on Tobacco Control, its policies exert significant indirect influence on U.S. state and loc... Read more The future of small businesses depends on affordable healthcare By Marcie Strouse Key Points Small businesses face a severe affordability crisis in providing employer-sponsored health insurance, with premiums rising more than 120 percent since 2000 an... Read more FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
Global anti-tobacco summit calls for vape flavor bans By HPN Staff Key Points Although the United States has not ratified the WHO Framework Convention on Tobacco Control, its policies exert significant indirect influence on U.S. state and loc... Read more The future of small businesses depends on affordable healthcare By Marcie Strouse Key Points Small businesses face a severe affordability crisis in providing employer-sponsored health insurance, with premiums rising more than 120 percent since 2000 an... Read more FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
The future of small businesses depends on affordable healthcare By Marcie Strouse Key Points Small businesses face a severe affordability crisis in providing employer-sponsored health insurance, with premiums rising more than 120 percent since 2000 an... Read more FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more 1 2 3 4 5 6 7
States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more
Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more
